Filing Flows

Filing Flows › Zimmer Biomet Holdings (ZBH) › Q2 2026

Zimmer Biomet Holdings (ZBH) Q2 2026 earnings results (second quarter 2026)

10-Q filed Aug 5, 2026

Zimmer Biomet Holdings (ZBH) reported revenue of $2.2B for the second quarter 2026 (Q2 2026), +5% from a year earlier and +4% from the quarter before. Operating margin was 15.0%, net earnings $200M (9.2% of revenue).

Revenue$2.2B
Year over year+5%
Quarter over quarter+4%
Operating margin15.0%
Net earnings$200M

Zimmer Biomet Holdings, Q2 2026: revenue $2.2B (+5% year over year), operating margin 15.0%, net earnings $200M, operating cash flow $448M. The chart follows the revenue to costs, profit and cash.

Q2 2026AmountQ/QY/Y
Revenue$2.2B+4%+5%
Operating profit$326M-13%+9%
Net earnings$200M-16%+30%
Operating cash flow$448M+25%+18%
Free cash flow$308M—+24%

What changed

Revenue was $2.2B in Q2 2026, up 5% year over year and up 4% from the previous quarter. Knees was the largest line at 38% of revenue. SET added $0.04B year over year (up 6%), 36% of the total change.

Operating profit was $0.33B, a 15.0% margin (up 0.5 points year over year). Of the extra revenue versus Q2 2025, 26% reached operating profit, above the 14% margin then. Total costs grew 4% against revenue growth of 5%. The fastest-growing cost line was SG&A (+10%). Net earnings were $0.20B, up 30% year over year. The effective tax rate was 21.8%.

Operating cash flow was $0.45B (up 18% year over year), 224% of net earnings. Non-cash charges added back $0.27B of depreciation and amortization and $0.02B of share-based compensation. Working capital and other items used $0.05B. After itions to instruments ($0.09B) and itions to other property, plant and equipment ($0.05B), free cash flow as the company reports it was $0.31B.

Questions

What was Zimmer Biomet Holdings' revenue in the second quarter 2026?

Zimmer Biomet Holdings (ZBH) reported revenue of $2.2B for the second quarter 2026 (Q2 2026), +5% from a year earlier and +4% from the quarter before.

Was Zimmer Biomet Holdings profitable in the second quarter 2026?

Operating profit was $326M (15.0% of revenue) and net earnings $200M.

Open the interactive Sankey →

Source: Zimmer Biomet Holdings 10-Q on SEC EDGAR.